Different levels of immunogenicity of two strains of Fowlpox virus as recombinant vaccine vectors eliciting T-cell responses in heterologous prime-boost vaccination …
MG Cottingham, A van Maurik, M Zago… - Clinical and vaccine …, 2006 - Am Soc Microbiol
MG Cottingham, A van Maurik, M Zago, AT Newton, RJ Anderson, MK Howard, J Schneider…
Clinical and vaccine immunology, 2006•Am Soc MicrobiolThe FP9 strain of Fowlpox virus has been described as a more immunogenic recombinant
vaccine vector than the Webster FPV-M (FPW) strain (RJ Anderson et al., J. Immunol. 172:
3094-3100, 2004). This study expands the comparison to include two separate recombinant
antigens and multiple, rather than single, independent viral clones derived from the two
strains. Dual-poxvirus heterologous prime-boost vaccination regimens using individual
clones of recombinant FP9 or FPW in combination with recombinant modified Vaccinia virus …
vaccine vector than the Webster FPV-M (FPW) strain (RJ Anderson et al., J. Immunol. 172:
3094-3100, 2004). This study expands the comparison to include two separate recombinant
antigens and multiple, rather than single, independent viral clones derived from the two
strains. Dual-poxvirus heterologous prime-boost vaccination regimens using individual
clones of recombinant FP9 or FPW in combination with recombinant modified Vaccinia virus …
Abstract
The FP9 strain of Fowlpox virus has been described as a more immunogenic recombinant vaccine vector than the Webster FPV-M (FPW) strain (R. J. Anderson et al., J. Immunol. 172:3094-3100, 2004). This study expands the comparison to include two separate recombinant antigens and multiple, rather than single, independent viral clones derived from the two strains. Dual-poxvirus heterologous prime-boost vaccination regimens using individual clones of recombinant FP9 or FPW in combination with recombinant modified Vaccinia virus Ankara expressing the same antigen were evaluated for their ability to elicit T-cell responses against recombinant antigens from Plasmodium berghei (circumsporozoite protein) or human immunodeficiency virus type 1 (a Gag-Pol-Nef fusion protein). Gamma interferon enzyme-linked immunospot assay and fluorescence-activated cell sorting assays of the responses to specific epitopes confirmed the approximately twofold-greater cellular immunogenicity of FP9 compared to FPW, when given as the priming or boosting immunization. Equality of transgene expression in mouse cells infected with the two strains in vitro was verified by Western blotting. Directed partial sequence analysis and PCR analysis of FPW and comparison to available whole-genome sequences revealed that many loci that are mutated in the highly attenuated and culture-adapted FP9 strain are wild type in FPW, including the seven multikilobase deletions. These “passage-specific” alterations are hypothesized to be involved in determining the immunogenicity of Fowlpox virus as a recombinant vaccine vector.
American Society for Microbiology
以上显示的是最相近的搜索结果。 查看全部搜索结果